BIO Institutional Ownership & Shareholders

BIO-RAD LABORATORIES-A (BIO) is currently held by 395 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $5.63B based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.

First Eagle U.S. Value is currently the largest disclosed institutional shareholder of BIO tracked by InsiderSet, reporting ownership valued at approximately $765.21M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $969.98M, representing an estimated gain of +26.76% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 51% of the total disclosed BIO value among the investors covered in this analysis. Major shareholders include First Eagle U.S. Value, Blackrock, Inc., Dimensional Fund Advisors Lp, and several other long-term asset managers with concentrated positions in BIO-RAD LABORATORIES-A (BIO).

This page ranks the largest institutional BIO shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

395

Total Reported Value

$5.63B

Largest Holder

First Eagle U.S. Value

Largest Position

$765.21M

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

51

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
First Eagle U.S. ValueJean-Marie Eveillard1.26%2,606,219$765,211,916$969,982,587+$204,770,671+26.76%
Blackrock, Inc.0.01%1,698,929$498,822,581$632,307,395+$133,484,814+26.76%
Dimensional Fund Advisors Lp0.05%944,548$277,332,178$351,541,875+$74,209,697+26.76%
Vanguard Capital Management Llc0.01%826,972$242,807,249$307,782,439+$64,975,190+26.76%
Ariel Appreciation FundJohn W. Rogers Jr.2.39%816,751$239,806,261$303,978,387+$64,172,126+26.76%
Vanguard Portfolio Management Llc0.01%816,198$239,643,895$303,772,572+$64,128,677+26.76%
Earnest Partners Llc0.61%580,752$170,514,595$216,144,279+$45,629,684+26.76%
State Street Corp0.00%571,762$167,875,041$212,798,381+$44,923,340+26.76%
Bank Of America Corp0.01%490,412$143,989,880$182,521,538+$38,531,658+26.76%
Capital World Investors0.02%462,457$135,782,000$172,117,246+$36,335,246+26.76%
Capital Research Global Investors0.02%443,483$130,211,044$165,055,503+$34,844,459+26.76%
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc0.02%426,038$118,758,094$158,562,823+$39,804,729+33.52%
First Pacific Advisors, Lp1.46%401,861$117,990,408$149,564,627+$31,574,219+26.76%
Geode Capital Management, Llc0.01%347,575$102,076,657$129,360,464+$27,283,807+26.73%
Nomura Holdings Inc0.41%328,897$96,567,448$122,408,885+$25,841,437+26.76%
Ubs Group Ag0.01%308,325$90,527,304$114,752,399+$24,225,095+26.76%
Sei Investments Co0.07%273,377$80,262,877$101,745,452+$21,482,575+26.77%
Barclays Plc0.02%267,634$78,580,020$99,608,022+$21,028,002+26.76%
Deerfield Management Company, L.P.0.69%226,070$66,376,413$84,138,733+$17,762,320+26.76%
Northern Trust Corp0.01%218,285$64,090,660$81,241,311+$17,150,651+26.76%
Charles Schwab Investment Management Inc0.01%195,538$57,411,913$72,775,333+$15,363,420+26.76%
Aqr Capital Management Llc0.02%192,710$56,045,867$71,722,808+$15,676,941+27.97%
Morgan Stanley0.00%190,285$55,870,130$70,820,271+$14,950,141+26.76%
Assenagon Asset Management S.A.0.06%147,506$55,714,491$54,898,783-$815,708-1.46%
Goldman Sachs Group Inc0.01%181,225$53,209,473$67,448,321+$14,238,848+26.76%
Sg Americas Securities, Llc0.03%170,802$50,149,000$63,569,088+$13,420,088+26.76%
Gw&K Investment Management, Llc0.38%166,905$49,006,000$62,118,703+$13,112,703+26.76%
Gotham Asset Management, Llc0.11%166,262$48,816,186$61,879,391+$13,063,205+26.76%
Freestone Grove Partners Lp0.27%140,113$41,138,578$52,147,256+$11,008,678+26.76%
Boston Trust Walden Corp0.32%105,556$39,869,556$39,285,832-$583,724-1.46%
Thompson Siegel & Walmsley Llc0.69%129,881$38,134,000$48,339,111+$10,205,111+26.76%
Mangrove Partners Im, Llc2.45%127,191$37,344,550$47,337,946+$9,993,396+26.76%
Hosking Partners Llp1.28%95,472$36,060,729$35,532,769-$527,960-1.46%
Victory Capital Management Inc0.02%122,126$35,857,415$45,452,855+$9,595,440+26.76%
Fisher Asset Management, Llc0.01%116,909$34,325,650$43,511,192+$9,185,542+26.76%
Vanguard Fiduciary Trust Co0.01%114,403$33,589,865$42,578,509+$8,988,644+26.76%
Bank Of New York Mellon Corp0.01%113,854$33,428,798$42,374,182+$8,945,384+26.76%
Exchange Traded Concepts, Llc0.15%87,691$33,121,768$32,636,836-$484,932-1.46%
Ing Groep Nv0.16%112,700$33,089,847$41,944,686+$8,854,839+26.76%
Norges Bank0.00%111,580$32,761,004$41,527,844+$8,766,840+26.76%
Envestnet Asset Management Inc0.01%105,449$30,960,831$39,246,009+$8,285,178+26.76%
Jpmorgan Chase & Co0.00%102,605$30,546,009$38,187,529+$7,641,520+25.02%
Manufacturers Life Insurance Company, The0.02%101,580$29,824,904$37,806,044+$7,981,140+26.76%
Wells Fargo & Company/Mn0.00%97,500$28,626,839$36,287,550+$7,660,711+26.76%
First Trust Advisors Lp0.02%94,209$27,660,592$35,062,706+$7,402,114+26.76%
Jne Partners Llp10.68%88,511$25,987,715$32,942,024+$6,954,309+26.76%
Allianz Asset Management Gmbh0.02%87,780$25,773,086$32,669,960+$6,896,874+26.76%
Natixis Advisors, Llc0.03%82,389$24,190,000$30,663,538+$6,473,538+26.76%
Jones Financial Companies Lllp0.01%78,878$23,725,684$29,356,814+$5,631,130+23.73%
Mawer Investment Management Ltd.0.14%71,577$21,015,723$26,639,528+$5,623,805+26.76%
Showing 50 of 395

Frequently asked questions about BIO

  • Who are the largest institutional holders of BIO?

    The largest institutional holders of BIO reported in the latest SEC Form 13F filings include First Eagle U.S. Value, Blackrock, Inc., Dimensional Fund Advisors Lp, Vanguard Capital Management Llc, and Ariel Appreciation Fund. InsiderSet ranks institutional holders by their latest reported BIO position.

  • What is BIO institutional ownership?

    This page tracks BIO positions reported by institutional investment managers through SEC Form 13F. BIO-RAD LABORATORIES-A (BIO) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.

  • How many institutions own BIO?

    InsiderSet currently tracks 395 institutional managers reporting BIO holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of BIO shareholders.

  • How much BIO stock do institutions own?

    Institutional investment managers disclosed approximately $5.63B in BIO holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.

  • When was BIO institutional ownership last updated?

    The latest BIO institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.

  • Are institutional BIO holdings real-time?

    No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its BIO position after the reporting date.

  • Are institutions buying or selling BIO?

    Institutional buying and selling can be analyzed by comparing BIO positions across consecutive 13F reporting periods. InsiderSet's BIO Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View BIO ownership changes.

  • How has BIO institutional ownership changed over time?

    InsiderSet tracks BIO institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.